The Theory Of Everything--What's Knowable And What's Not

Editor's Note: By Julia King How convenient it would be for scientists if there existed a Theory of Everything, some ultimate explanation for all that goes on and doesn't go on in the universe around us. What would constitute such a theory? According to British astronomer and writer John D. Barrow, any comprehensive understanding of the world, and thus a Theory of Everything, would need to incorporate eight essential ingredients, which he explores, chapter by chapter, in a new book. These are:

Written byJohn Barrow
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

How convenient it would be for scientists if there existed a Theory of Everything, some ultimate explanation for all that goes on and doesn't go on in the universe around us. What would constitute such a theory? According to British astronomer and writer John D. Barrow, any comprehensive understanding of the world, and thus a Theory of Everything, would need to incorporate eight essential ingredients, which he explores, chapter by chapter, in a new book. These are: laws of Nature, initial conditions, the identity of forces and particles, constants of Nature, broken symmetries, organizing principles, selection biases, and categories of thought. But even with these ingredients in place, is a Theory of Everything indeed achievable by scientists? Or, are there other necessary ingredients, which defy observation, much less quantification?

This is the question Barrow explores in the following excerpt from his new book, Theories of Everything: The Quest for Ultimate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies